Abstract

Direct acting antivirals for patients without advanced liver disease: All for treatment and treatment for all?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
... Christine M Durand
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | VOL. 21
, et. al. ... Christine M Durand
23 Dec 2020
Hepatitis‐Viral
-
Journal of Gastroenterology and Hepatology | VOL. 32
--
01 Aug 2017
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
Anna S Lok ... Pratima Sharma
Gastroenterology | VOL. 141
Anna S Lok, et. al.Anna S Lok ... Pratima Sharma
25 Oct 2011
JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.
Atsushi Tanaka ... Hajime Takikawa
Hepatology research : the official journal of the Japan Society of Hepatology | VOL. 46
Atsushi Tanaka, et. al.Atsushi Tanaka ... Hajime Takikawa
01 Feb 2016
View more papers

More From: Hepatology (Baltimore, Md.)

Paper Title
Journal
Date
Author
Hepatology Highlights.
-
Hepatology (Baltimore, Md.) | VOL. 79
--
01 Jun 2024
Erratum: Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
-
Hepatology (Baltimore, Md.) | VOL. 79
--
01 Jun 2024
Fellows' Corner.
Robert M Wilechansky
Hepatology (Baltimore, Md.) | VOL. 79
Robert M WilechanskyRobert M Wilechansky
01 Jun 2024
Platelet-mediated circulating tumor cell evasion from natural killer cell killing via immune checkpoint CD155-TIGIT.
Yunfan Sun ... Wei Guo
Hepatology (Baltimore, Md.) | VOL. -
Yunfan Sun, et. al.Yunfan Sun ... Wei Guo
23 May 2024
View more papers